Arcutis Biotherapeutics, Inc. (ARQT)
23.66
+0.02
(+0.11%)
USD |
NASDAQ |
Apr 06, 16:00
23.68
+0.02
(+0.11%)
After-Hours: 20:00
Arcutis Biotherapeutics SG&A Expense (TTM) : 274.55M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| ADMA Biologics, Inc. | 96.42M |
| Axsome Therapeutics, Inc. | 570.60M |
| Arcus Biosciences, Inc. | 110.00M |
| Mirum Pharmaceuticals, Inc. | 257.03M |